Narkhede Neha 4

4 · Confluent, Inc. · Filed Feb 18, 2026

AI-generated summary of this filing

Updated Feb 19, 2026

Confluent (CFLT) Director Neha Narkhede Sells 80,000 Shares

What Happened

Neha Narkhede, a director of Confluent, converted/exercised derivative securities to acquire 80,000 shares and sold 80,000 shares in an open-market transaction on Feb 13, 2026. The sale generated approximately $2,447,200 (average reported price ~$30.59). The filing shows conversion/exercise (derivative codes C and M) and an immediate sale (S) of the same 80,000 shares.

Key Details

Transaction date: February 13, 2026.
Sale: 80,000 shares disposed in open market at reported average ~$30.59; total proceeds ≈ $2,447,200. Footnote indicates sales ranged $30.53–$30.64.
Derivative activity: Conversion/exercise entries (codes C and M) for 80,000 shares indicate derivatives were converted/exercised to produce the shares sold.
Plan/authorization: Shares sold pursuant to a 10b5-1 trading plan adopted June 10, 2025 (footnote F2).
Vesting: Shares/derivatives were fully vested (footnote F4).
Shares owned after transaction: not specified in the provided filing excerpt.
Filing timeliness: Form 4 filed Feb 18, 2026 — one business day after the typical 2-business-day Form 4 deadline (appears late).

Context

This was a sale, which is commonly routine for insiders and does not by itself indicate company outlook. The filing shows a same-day conversion/exercise followed by a sale — effectively a cashless or immediate-sale of shares obtained via derivatives. Footnote F1 explains Class B common stock may convert into Class A upon sale, which can be the mechanism used here. The sale was executed under a pre-established 10b5-1 plan, which typically schedules trades in advance.

Form 4

Period: 2026-02-13

Director

Transactions

Conversion
Class A Common Stock
[F1]
2026-02-13+80,000→ 108,549 total
Sale
Class A Common Stock
[F2][F3]
2026-02-13$30.59/sh−80,000$2,447,200→ 28,549 total
Exercise/Conversion
Stock Option (Right to Buy)
[F4]
2026-02-13−80,000→ 377,502 total
Exercise: $2.24Exp: 2028-10-21→ Class B Common Stock (80,000 underlying)
Exercise/Conversion
Class B Common Stock
[F1]
2026-02-13+80,000→ 1,163,729 total
→ Class A Common Stock (80,000 underlying)
Conversion
Class B Common Stock
[F1]
2026-02-13−80,000→ 1,083,729 total
→ Class A Common Stock (80,000 underlying)

Holdings

Footnotes (4)

[F1]Each share of Class B Common Stock held by the Reporting Person will automatically convert into one share of Class A Common Stock upon the sale or transfer of such share of Class B Common Stock, subject to certain exceptions, and in certain other circumstances described in the Issuer's amended and restated certificate of incorporation. Each share of Class B Common Stock will also be convertible at any time at the option of the Reporting Person into one share of Class A Common Stock.
[F2]Shares sold pursuant to a 10b5-1 plan adopted June 10, 2025.
[F3]The shares were sold at prices ranging from $30.53 to $30.64. The reporting person will provide to the SEC, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F4]Fully vested.

Signature

/s/ Weilyn Wood, Attorney-in-Fact|2026-02-18

1 file